This video was published 508 Days 3 Hours 42 Mins ago.
Member Access: Available NOW Public Access: Available NOW
THE 3 MINUTE PRESS SHOW with Tracee Tolentino
Discover the News behind the News from today's leading executives. Each day we interview the leading Executives on the press of that day.
The 3 Minute Press Show gives you the:
Who, What, Where, When, Why and How of this Press and how it will impact the company and its shareholders.
Members are encouraged to ask these executives questions through their message boards at Mywallst
GeoVax Labs, Inc. is a biotechnology company, established to develop, manufacture, license and commercialize human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents. GeoVax's AIDS vaccine technology is the subject of 20 issued or filed patent applications. GeoVax AIDS vaccines are designed for use in uninfected people to prevent Acquired Immunodeficiency Disease (AIDS), caused by the virus known as HIV-1, should the person ever become infected. GeoVax AIDS vaccines also may be effective as therapeutics (treatment of people already infected with AIDS virus). Studies evaluating these vaccines in HIV/AIDS infected individuals are in the planning stage. GeoVax's core AIDS vaccine technologies were developed through a collaboration of colleagues at Emory University's Vaccine Center, the National Institutes of Health (NIH), The Centers for Disease Control and Prevention (CDC) and the GeoVax team. GeoVax AIDS vaccines have moved forward in human clinical trials conducted by the HIV Vaccine Trials Network (HVTN) based in Seattle, Washington. The HVTN, funded through a cooperative agreement with the National Institutes of Health [NIH), is the largest worldwide clinical trials program dedicated to the development and testing of AIDS vaccines. Preclinical work enabling evaluation of GeoVax DNA and MVA vaccines was funded and supported by NIAID, which provided additional support to GeoVax AIDS vaccine development program with a $15 million IPCAVD grant awarded in late 2007.
does that mean the stock could come off the otcbb maybe?
tracee's tits
Posted By: dauphinater - 506 Days 12 Hours 36 Mins
Position: None
Man her boobs are busting out of her shirt.
Onslaught of AIDS an outrage against humanity shames and diminishes us all.
Posted By: GRooveLlama - 506 Days 21 Hours 29 Mins
Position: None
I've been following the company for quite some time. There may be some pretty crazy offers down the road but I believe Emory University owns more than half of the company and due to the potential that GeoVax could become their flagship biotech, someday, selling it would be like shooting themselves in the foot; furthermore, other Emory-based (although, not publicly traded) biotech companies are trading in the $8 to $20 range and it is my opinion that given time GOVX could, potentially, surpass them all. Mr. McNally was very correct in stating that the world needs a vaccine to take the place of much more expensive medications for combating HIV/AIDS. I have heard accounts that finding a child over the age of 10 in regions of sub-Saharan Africa whose parents have not yet succumbed to this disease can be difficult. The Millennium Development Goals of 2015, set by the G8 nations a few years back, promises to "halt and reverse" the spread of HIV/AIDS as well as other communicable diseases such as malaria. It could be that short of pumping hundreds of millions into this company to ensure adequate funding for research, not one of the high-prevalence HIV countries will see this goal realized by that time. Such a vaccine means that the number of times a patient must be treated is far less than with conventional treatments and coupled with the fact that large quantities can be manufactured quickly and relatively inexpensively, there is a real chance that the "tide could turn" so-to-speak in the most beleaguered populations. African children are being starved to pay of the continent's debt and those dying of HIV/AIDS are denied medical treatment due to the high expense that such treatment entails. GeoVax's vaccine, once FDA approved (after what I hope to be a fast-tracked 3rd-stage human-clinal trial) could bring hope to the governments of African countries (Zambia, for example) or India and China so that they can, at least, have a fighting chance of halting the spread of HIV/AIDS. Co-founder of GeoVax and V.P. of R.&D., Dr. Harriet Robinson, has devoted her life to this cause. After more than 20 years of vaccine-related research, I now believe that her dream will soon be realized and to the momentous benefit of science as well as mankind.
Most AIDS conferences state the that most vaccine tests have failed
Based on news lately where companies are going back to basics as the current approach has not worked and now that GeoVax is only one of 2 companies at this Phase 2 trial stage, what is the probability that GEOVAX could be acquired.
General Electric Company (GE) operates as a technology, media, and financial services company worldwide. It operates through four segments: GE Capital, Energy Infrastructure, Technology Infrastructure…
Founded in 1960, Domino's Pizza is the recognized world leader in pizza delivery. Through its primarily locally-owned and operated franchised system, Domino's operates a network of 8,726 franchised and…
Starwood Hotels & Resorts Worldwide, Inc., together with its subsidiaries, operates as a hotel and leisure company worldwide. It primarily operates luxury and upscale full service hotels, retreats, and…
Make WallSt.net My Homepage!
Featured Company:
